BATF2 and glioblastoma: Analysis of publicly available data from The Cancer Genome Atlas in GBM revealed that patients with high BATF2 expression had improved survival outcomes compared with those with low expression, and that overall BATF2 transcript levels were elevated in GBM samples relative to nontumor controls.